Financial insights of KMTS

MyFinsight

Income Statement	2026-01-31	2025-10-31	2025-07-31
Revenue	24,552	22,565	NaN
Cost of revenue	11,646	11,141	NaN
Gross profit	12,906	11,424	NaN
Research and development	4,972	4,878	NaN
Selling, general and administrative	42,699	38,301	NaN
Total operating expenses	47,671	43,179	NaN
Loss from operations	-34,765	-31,755	NaN
Interest expense	1,888	1,901	NaN
Interest income	2,163	1,796	NaN
Other expense (income)	359	-891	NaN
Net loss before provision for income taxes	-34,131	-32,751	NaN
Provision for income taxes	35	34	NaN
Net loss and comprehensive loss	-34,166	-32,785	NaN
Net loss and comprehensive loss attributable to kestra medical technologies, ltd	-34,166	-32,785	-25,826
Net loss attributable to common shareholders, diluted	NaN	NaN	-25,826
Net loss attributable to common shareholders, basic	-34,166	-32,785	NaN

Basic EPS	-0.61	-0.64	-0.5
Diluted EPS	-0.61	-0.64	-0.5
Basic Average Shares	55,848,413	51,376,278	51,304,599
Diluted Average Shares	55,848,413	51,376,278	51,304,599

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.